搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
1 天
Scientists Identify Protein That Could Alleviate Parkinson’s Disease
A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for ...
BioTechniques
13 天
Mapping Parkinson’s progression in 3D
Yasir Gallero-Salas discusses quantifying alpha-synuclein spread and dopaminergic neuron loss in a model of Parkinson’s using ...
precisionmedicineonline
2 小时
BioArctic Doses First Parkinson's Patient in Trial of Alpha-Synuclein-Targeting Drug
Exidavnemab is a monoclonal antibody designed to eliminate aggregated clumps of the protein biomarker and slow progression of Parkinson's disease.
3 小时
AbbVie Says Phase 3 TEMPO-2 Study Of Tavapadon In Early Parkinson's Disease Met Main Goal
Monday said Phase 3 TEMPO-2 study evaluating tavapadon in early Parkinson's disease met its primary goal. In the ...
Viral Chatter on MSN
5 天
New Study Links Gut Health to Parkinson’s Disease Onset
Nearly one million people in the U.S. are living with Parkinson’s disease (PD), and this number is expected to grow to 1.2 ...
Yahoo Finance
3 天
BioArctic doses first subject in Parkinson’s disease therapy trial
Exidavnemab is being developed as a potential disease-modifying treatment, aiming to halt or slow the progression of ...
sciencex
5 天
World-first clinical trial hopes to stop Parkinson's in its tracks
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Medical Xpress on MSN
13 天
New biomarkers could improve diagnosis and tracking of Parkinson's disease and Lewy body ...
Participant data from three independent studies were evaluated: the Parkinson's Progression Markers Initiative (PPMI), the ...
GEN
4 天
Gene and Cell Therapies Take Aim at Parkinson’s Disease
New therapies that are less intrusive but more lasting than current interventions promise to arrest and even reverse neurodegeneration.
precisionmedicineonline
4 天
Gain Therapeutics to Start Testing GCase-Targeted Drug in Patients with GBA1, Sporadic ...
The company is hoping to show GT-02287 can slow Parkinson's progression by restoring function of GCase, an enzyme encoded by ...
7 天
A Denver artist and his visual journey through Parkinson’s Disease
When Denver artist Tim McKay was diagnosed with Parkinson’s disease last year, he made a quick decision: He would document ...
Pharmabiz
2 天
BioArctic begins patient dosing in EXIST phase 2a study in Parkinson’s disease
BioArctic begins patient dosing in EXIST phase 2a study in Parkinson’s disease: Stockholm Saturday, December 7, 2024, 18:00 Hrs [IST] BioArctic AB (publ), a Swedish research-bas ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈